Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report-Reference-Cited by-同舟云学术

Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report

Published:2022-12-20 Issue:2 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Huang Jiayi¹,Chen Xiao¹,Guo Jinfeng¹,Song Lin¹,Mu Yanxi¹,Zhao Han¹,Du Caiwen¹

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong 518116, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. HER2-positive breast cancer;Loibl;Lancet,2017

3. Breast cancer stage at diagnosis and area-based socioeconomic status: A multicenter 10-year retrospective clinical epidemiological study in China;Wang;BMC Cancer,2012

4. A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer;Heinemann;Ann Oncol,2011

5. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: Final analysis of the HERceptin Adjuvant (HERA) trial;Cameron;Lancet,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases;Frontiers in Pharmacology;2024-08-19

2. Novel Approaches to Bypassing the Blood-Brain Barrier for Drug Delivery to Brain Tumors;Interdisciplinary Cancer Research;2024